We are live on ! Find out more
ALBT

Avalon GloboCare

Delisted

ALBT was delisted on the 21st of July, 2026.

20 hedge funds and large institutions have $432K invested in Avalon GloboCare in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

25% more funds holding

Funds holding: 1620 (+4)

0% less ownership

Funds ownership: 0.01%0.01% (-0%)

31% less capital invested

Capital invested by funds: $625K → $432K (-$193K)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
20
Holders Change
+4
Holders Change %
+25%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
5
Closed
1
Calls
Puts
Net Calls
Net Calls Change

ALBT Hedge Fund Activity: Q2 2022 in Review

20 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Avalon GloboCare (ALBT) for Q2 2022, worth a combined $432K — down 31% from $625K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ALBT positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 5 trimmed.

The largest buyer was Tower Research Capital (TRC), adding an estimated $13.8K. The largest seller was BlackRock, cutting an estimated $33K.

  • 20 institutional investors held Avalon GloboCare (ALBT) as of Q2 2022, up from 16 in Q1 2022.
  • Funds reported $432K of Avalon GloboCare stock for Q2 2022, down 31% quarter-over-quarter.
  • 5 funds opened new Avalon GloboCare positions in Q2 2022 and 1 closed out, a net change of +4 holders.
  • The largest Avalon GloboCare buyer in Q2 2022 was Tower Research Capital (TRC), an estimated $13.8K added.
  • The largest Avalon GloboCare seller in Q2 2022 was BlackRock, an estimated $33K sold.

Based on aggregated 13F filings for Q2 2022.